Growth Metrics

Innoviva (INVA) Finished Goods (2013 - 2026)

Innoviva posted quarterly Finished Goods of $4.1 million for Q1 2026, up 18.17% year-on-year from $3.4 million in Q1 2025, and down 18.35% on a QoQ basis from $5.0 million in Q4 2025.

Innoviva (INVA) has 7 years of Finished Goods data on file, last reported at $4.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Finished Goods rose 18.17% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at $4.1 million (up 18.17% YoY), and the FY2025 full-year result was $5.0 million, up 138.65% from the prior year.
  • Finished Goods for Q1 2026 stood at $4.1 million, down from $5.0 million in the prior quarter.
  • Across five years, Finished Goods topped out at $25.1 million in Q4 2022 and bottomed at $2.1 million in Q4 2024.
  • The 5-year median for Finished Goods is $5.3 million (2025), against an average of $9.6 million.
  • The widest annual swing landed in 2024, when Finished Goods tumbled 84.92%; it then surged 138.65% in 2025.
  • A 5-year view of Finished Goods shows it stood at $25.1 million in 2022, then tumbled by 44.95% to $13.8 million in 2023, then slumped by 84.92% to $2.1 million in 2024, then soared by 138.65% to $5.0 million in 2025, then dropped by 18.35% to $4.1 million in 2026.
  • The last three Finished Goods figures came in at $4.1 million (Q1 2026), $5.0 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.06 Mn
Dec 31, 2025 4.97 Mn
Sep 30, 2025 5.32 Mn
Jun 30, 2025 4.30 Mn
Mar 31, 2025 3.44 Mn
Dec 31, 2024 2.08 Mn
Sep 30, 2024 4.31 Mn
Jun 30, 2024 4.34 Mn
Mar 31, 2024 7.72 Mn
Dec 31, 2023 13.81 Mn
Sep 30, 2023 18.43 Mn
Jun 30, 2023 14.12 Mn
Mar 31, 2023 21.36 Mn
Dec 31, 2022 25.09 Mn
Sep 30, 2022 10.92 Mn
Mar 31, 2014 4.79 Mn
Dec 31, 2013 4.91 Mn
Sep 30, 2013 1.35 Mn